Affiliation:
1. Limited liability company Inpromed
2. V.V. Vinogradov Hospital
Abstract
According to clinical guidelines self-monitoring of blood glucose is a part of the treatment of type 2 diabetes mellitus. However, self-monitoring of glycemia is associated with signifi cant costs. Th at’s why the issue if there is a possibility to decrease the use of self-monitoring of blood glucose is actual. Since the United Kingdom Prospective Study (UKPDS) showed that every 1% decrease in glycated hemoglobin leads to a 37% decrease in the risk of microvascular complications and 14% decrease in the risk of macrovascular complications as well as it leads to a decrease in mortality, the article mainly examined the eff ect of selfmonitoring on the level of glycated hemoglobin in various clinical situations.
Publisher
Rostov State Medical University
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference32 articles.
1. Dedov I.I., Shestakova M.V., Mayorov A.Y., Vikulova O.K., Galstyan G.R., et al. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition. Diabetes Mellitus. 2019;22(1s1):1-144. (in Russ.) DOI: 10.14341/DM221S1
2. Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol. 2012;6(5):1060-75. DOI: 10.1177/193229681200600510.
3. Antsiferov M.B., Koteshkova O.M. Diabetes mellitus management: organization and importance of self-control. Diffi cult patient. 2009;7(10):41–46. (in Russ.)eLIBRARY ID: 16908683
4. Peters ML, Huisman EL, Schoonen M, Wolff enbuttel BHR. Th e current total economic burden of diabetes mellitus in the Netherlands. Neth J Med. 2017;75(7):281-297. PMID: 28956787.
5. de Lagasnerie G, Aguadé AS, Denis P, Fagot-Campagna A, Gastaldi-Menager C. Th e economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach. Eur J Health Econ. 2018;19(2):189-201. DOI: 10.1007/s10198-017-0873-y.